PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Pharm Exec’s Emerging Eleven: Slide Show

UK Government (Finally) Responds to Accelerated Access Review

Taiwan’s Biotech Boom

Advertisement
Top Story
Ireland: Ideal for the European Medicines Agency?
Allergan’s CEO Brent Saunders explains why the European Medicines Agency should choose Dublin as its headquarters after leaving London
/Read more/
Advertisement
Looking for physician respondents for your surveys?
With advanced targeting, unmatched recruitment, and the industry’s leading network of active physicians, Medscape Market Research gets you the respondents and results you need.
Learn about the Medscape difference today.
Technology
Driving Decisions with Data: Sundeep Bhan, Prognos
Pharm Exec speaks to Prognos CEO Sundeep Bhan about how the company’s unique offering will reach beyond life sciences as the long-promised benefits of AI become reality
/Read more/
Advertisement
Free White Paper: Customer Experience in Pharma with UCB, Teva and Pfizer.
5 case studies from industry leaders on how they are exceeding customers expectations and creating "wow" moments.
Learn more
Event
Rewarding Creative Thinking in Oncology: The Astellas C3 Prize
Ahead of this week’s announcement of the winning entry, Mark Reisenauer, SVP, Oncology Business Unit at Astellas, spoke to PharmExec about the development and objectives of the Astellas Oncology C3 Prize
/Read more/
Advertisement
Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
On Demand
Learn more
ADVERTISEMENT
Calendar
/ November 28–29: Commercial Data Insights /
Philadelphia, PA
/ December 4–5: Connected Devices in Healthcare /
San Diego, CA
/ December 12: Specialty Products Data Strategy Summit /
Philadelphia, PA
/ January 23–24: 13th Biosimilars Summit /
Alexandria, VA
/ January 24–25: Reimbursement and Contracting /
Philadelphia, PA
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
/ March 25–28, 2018: 14th Annual Pharma Forum /
Philadelphia, PA
/ March 28–29, 2018: Expanded Access Programs /
Washington, DC
/ April 11–12, 2018: 8th Annual Global Transparency Reporting Congress /
London, UK
Advertisement
Risk Sharing
Engaging in Risk-Sharing Agreements with Providers
Before entering into risk-sharing agreements, manufacturers must understand the challenges and implications, writes Kimberly E. White
/Read more/
Special Feature
Pharm Exec's 2018 Pipeline Report
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods—and the realization that failures have their place in shaping the pipeline of tomorrow. Josh Baxt reports
/Read more/
Industry update
//Aerpio Therapeutics (Cincinnati,OH) appointed Michael Rogers as chief financial office, effective November 15, 2017. //Astellas (Northbrook, IL) announced two senior-level changes in its US commercial organization within the company’s Health Systems business unit. James Miteff was promoted to national vice president, Health Systems Payer & Channel Account Management. Gregory Apostol was promoted to national vice president, Key Account Management. Miteff is replacing Bruce Mazer, vice president of the Health Systems Payer Account Management organization, who is retiring after a 17-year tenure. //Cancer Research UK and the University of Cambridge announced the appointment of Professor Greg Hannon as the new director of the Cancer Research UK Cambridge Institute.
ADVERTISEMENT
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com